chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I have an IUD and haven?t had a period in over a year. The day after the vaccine I got severe menstrual cramping and have experienced it on and off for a few days. Dec 5, 2021, I got a period. It?s no big deal but weird.  Also have a lump  and tenderness in left arm pit
I went on Wednesday evening for my 2nd dose o f the Jynneos vaccine (first dose was received on July 22, 2022 with no affects). It was being offered by the CDC at the bar both times. I sat down at the table (which had been steralized and covered with plastic and medical paper toweling), and a young man with mask and gloves stuck my inner left forearm four times, but he was not able to get the right angle to just get under the skin to administer the vaccine. He called a co-worker over, who was able to administer the vaccine in my forearm just to the left of the original four pokes. So I was a poked a total of 5 times with two separate needles of the vaccine. On Thursday the 25th, my arm felt itchy around 10am, but no swelling. At 5pm I noticed the fifth injection site was swollen and warm. At 9pm  I placed a cold compress on the injection site to help with the swelling and heat. At 7am on 8/26/22 I woke up to see my forearm had swollen significantly and was itchy and burned when touched. I sent a message with photo of the swelling via MyChart to my PCP at 8:28am, she responded at 9:03am, telling me to take Benadryl or Claritin for the itching and said it seemed to be a local reaction. She also said if anything changes to let her know.
Allergic reaction around injection site w/extensive blistering. Pt. given loratadine by MD to control reaction. She is to report back if reaction doesn't resolve.
This spontaneous report as received from a nurse via a field employee refers to a 36 year old female patient. The concurrent condition and medical history was not reported. On unknown dates the patient (when she was a child) was vaccinated with dose 1 and dose 2 of M-M-R II. The concomitant medication was not reported. On an unknown date, the patient had titers drawn which showed that she had no immunity at all for measles, mumps or rubella (antibody test negative). The patient sought medical attention by making a visit to the nurse. The outcome of antibody test negative was unknown. The causality was unknown. Additional information is not expected due to lack of consent for follow up.
Lightheaded (almost fainting for 24 hours) 103 temp, body aches like nothing I?ve ever felt.  Extreme pain at injection site.  Chills.  Joint and sling pain.  Earlobe pain.  Headache.  Worst flu-like experience ever.
The day after my arm was sore and 2 days after. Swelled lymph nodes in arm and the lymph nodes in armpit. I have a lot of pain in armpit. Then like around the 3 rd Maybe  4 days after. I notice my smell is off and hardly can taste food.  And as of today july/6 i still hardly can smell or taste anything. My armpit lymph nodes  still swelled and still in pain. My hole arm is not sore no more. Just the armpit
Within seconds after administering Meningococcal B (BEXSERO) the patient appeared unconscious. Pt then started to breathe heavy, teeth clenched, stiffening up and pupils dilated with eyes rolling into back of her head. Pt then urinated, was layed down and was tight and stiff with all four extremities flailing. Pt clearly was having a seizure with no history of this.
Information has been received from a licensed practical nurse concerning an approximately 10 year old patient who on 11-SEP-1998 was vaccinated with a dose of VARIVAX (Merck). On approximately 10-APR-2008, the patient experienced 1 to 2 lesions. At the time of the report, the patient's outcome was unknown. This is one of several reports received from the same source. No further information is available.
Immediate numbness of bilateral arm x 5 min. frontal headache, leading to bilateral paraspinal tightness and pain throughout entire back.
Presented to emergency department for evaluation of weakness and aphasia.  The patient has her eyes open on arrival.  She does follow commands with mild weakness to the right upper and lower extremities.  Mild right facial droop is noted on physical exam.  The patient does not speak otherwise. Initial CT concerning for ischemic stroke.  CTA with perfusion was then obtained that shows evidence of a small area of core infarct with a large area of penumbra.  Carotid occlusion from the bifurcation LP is noted on the left side with collateral circulation coming from the Act.   Patient transfered from this emergency department to tertiary care center for possible thrombectomy.
Noticed blurry vision in left eye. Went to Opthamologist who verified Branch Retinal Vein Occlusion. Treated with shot into eye of Eylea, to continue for 3 months before review. Blurry vision continues.
HEADACHE; feeling body ache; This spontaneous case was reported by a physician and describes the occurrence of HEADACHE (HEADACHE) and MYALGIA (feeling body ache) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced HEADACHE (HEADACHE) and MYALGIA (feeling body ache). On 21-Mar-2021, HEADACHE (HEADACHE) and MYALGIA (feeling body ache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided  No treatment medication was provided
Patient was seen in office c/o paresthesias and numbness with facial twitching on R side of face on cheek. Within two hours this had progressed to numbness to light touch and pinprick on exam from R temple to R mandible. No other neurological abnormalities were noted on exam. Vital signs were stable. No local site reaction noted of R arm. No fever. Patient was monitored for any progressive neuro changes and no progression was noted.  By Jan 09,2021 the numbness had completely resolved. No  further problems noted.
Arm soreness, fever, joint pains, headache w/in 24 hours of vaccine.
Rash around inj. site, fatigue, sore throat, facial swelling, redness of eyes, trouble swallowing.
I received this vaccine on 6/28/2019.  On 7/1/2019 about 4:30 pm I realized that I could not bend my index finger on my right hand without pain.  The next day I woke up and my right hand was twice the size of my left hand.  Pins and needles feeling in my hand.  Arm pain from elbow to shoulder blade.  I provided my er doctors info in a previous question.  Er diagnosed me with either adverse reaction to vaccine and/or cellulitis.  I've not had any issues before this with any vaccines.
Reported pain at injection site fever 101.8F, chills,diarrhea, chest tightness, shortness of breath. Took tylenol-symptoms resolved.
Severe dizziness, nausea, vomiting, hot sweats.  Occurred a little over 20 hrs & lasted 24 - 48 hrs.  No fever.
Severe back pain, severe GERD began about 3 hrs after vaccine adm. Resolved completely about 24 hours later, gradually improving prior. No treatment requested.
received a Moderno vaccine my last shot was on the first I was just told by my position that I have a side effect which is shingles; I am in so much pain it is awful; I am very upset; I cannot sleep; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER, PAIN, FEELING ABNORMAL, and INSOMNIA in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER, PAIN, FEELING ABNORMAL, and INSOMNIA. At the time of the report, HERPES ZOSTER, PAIN, FEELING ABNORMAL, and INSOMNIA outcome was unknown.            No Treatment medications were provided No  Concomitant medications were provided   Most recent FOLLOW-UP information incorporated above includes On 11-Sep-2021 a Follow up received with updated events.
w/in 24hr p/vax pt presented w/local reaction to lt thigh consisting of erythema, warmth & induration lateral to inj site;
The vials have been taken out of the Freezer on 25-MAY-2023 and were placed in Fridge on 05-JUN-2023 with a timed out date for 23-JUN-2023; No reported symptoms; patients received doses of vaccine after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patients received doses of vaccine after BUD), PRODUCT STORAGE ERROR (The vials have been taken out of the Freezer on 25-MAY-2023 and were placed in Fridge on 05-JUN-2023 with a timed out date for 23-JUN-2023) and NO ADVERSE EVENT (No reported symptoms) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7185B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 29-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 29-Jun-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (patients received doses of vaccine after BUD). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vials have been taken out of the Freezer on 25-MAY-2023 and were placed in Fridge on 05-JUN-2023 with a timed out date for 23-JUN-2023) and NO ADVERSE EVENT (No reported symptoms). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patients received doses of vaccine after BUD), PRODUCT STORAGE ERROR (The vials have been taken out of the Freezer on 25-MAY-2023 and were placed in Fridge on 05-JUN-2023 with a timed out date for 23-JUN-2023) and NO ADVERSE EVENT (No reported symptoms) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No reported symptoms) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (patients received doses of vaccine after BUD) and PRODUCT STORAGE ERROR (The vials have been taken out of the Freezer on 25-MAY-2023 and were placed in Fridge on 05-JUN-2023 with a timed out date for 23-JUN-2023).    Concomitant medication details not reported by the reporter. The vials were taken out of the freezer on 25-MAY-2023. The vials were placed in fridge on 05-JUN-2023 with a timed out date of 23-JUN-2023. It was reported that 2 patients had received their 6th doses and rest were 5th doses in this error. Dosage text was reported as unknown. Treatment details was not reported by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-732466, US-MODERNATX, INC.-MOD-2023-732468, US-MODERNATX, INC.-MOD-2023-732470, US-MODERNATX, INC.-MOD-2023-732474, US-MODERNATX, INC.-MOD-2023-732475 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-732470:Patient 2 US-MODERNATX, INC.-MOD-2023-732474:Patient 3 US-MODERNATX, INC.-MOD-2023-732466:Patient 4 US-MODERNATX, INC.-MOD-2023-732468:Patient 5 US-MODERNATX, INC.-MOD-2023-732475:Patient 6
no strength; can't stop sneezing; went to sleep right after the shot; diarrhea; constipation; his arm turned a little swollen; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (his arm turned a little swollen), CONSTIPATION (constipation), ASTHENIA (no strength), DIARRHOEA (diarrhea) and SNEEZING (can't stop sneezing) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included Novolin and another insulin (caller could not recollect name).    On 15-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced PERIPHERAL SWELLING (his arm turned a little swollen). On 13-May-2021, the patient experienced CONSTIPATION (constipation), DIARRHOEA (diarrhea) and SLEEP APNOEA SYNDROME (went to sleep right after the shot). On an unknown date, the patient experienced ASTHENIA (no strength) and SNEEZING (can't stop sneezing). On 29-May-2021, PERIPHERAL SWELLING (his arm turned a little swollen) outcome was unknown. At the time of the report, CONSTIPATION (constipation), ASTHENIA (no strength), DIARRHOEA (diarrhea), SNEEZING (can't stop sneezing) and SLEEP APNOEA SYNDROME (went to sleep right after the shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        No treatment medication was reported .   Reporter did not allow further contact
nausea; vomiting; headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non- HCP). The reporter is the patient.  A 44-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 23Oct2021 (Lot number: 3203080) at the age of 44 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "kidney failure stage 3" (unspecified if ongoing), notes: Stage 3; "Colitis" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EL3247, Location of injection: Arm Left), administration date: 22Mar2021, when the patient was 43 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EL3247, Location of injection: Arm Left), administration date: 01Mar2021, when the patient was 43 years old, for COVID-19 immunization. The following information was reported: NAUSEA (non-serious) with onset 23Oct2021 16:00, outcome "recovering", described as "nausea"; VOMITING (non-serious) with onset 23Oct2021 16:00, outcome "recovering", described as "vomiting"; HEADACHE (non-serious) with onset 23Oct2021 16:00, outcome "recovering", described as "headache". Therapeutic measures were not taken as a result of nausea, vomiting, headache.  Additional Information: Relevant past drug history includes Allergy. Facility where the most recent COVID-19 vaccine was administered is Other. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. List of any other medications the patient received within 2 weeks of vaccination: yes. Prior to vaccination, was the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The shot was administered to patient on Saturday 23Oct2021. She experienced the adverse effects later that same day.  No follow-up attempts are possible. No further information is expected.
PATIENT PREGNANT WITH NO ESTIMATED DELIVERY DATE.  EXPERIENCING STRONG HEART PALPITATIONS
Product storage in error; No adverse event; This spontaneous case was received from and healthcare professional regarding to a patient of unknown age, gender and ethnicity. The patient's concurrent conditions, medical history, drug allergies and concomitant therapies were not reported.   On 27-FEB-2021, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot # T027114 with expiration date reported as 07-FEB-2022) 0.5 (units not reported) (route of administration and anatomical location of vaccine were not reported) for prophylaxis. The vaccine was exposed to a temperature between 5.0 °F and 8.0 °F for 8 hours and 40 minutes. A previous temperature excursion was reported. No adverse effect was reported.  Albumin status has been verified for measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot # T027114) to be recombinant human albumin (rHa).  This is one of several reports received from the same source.; Sender's Comments:  US-009507513-2103USA003425:
During the evening, overnight and the following day until Noon, I was hyper-agitated and hyper-irritable. It started abruptly and ended abruptly. Nothing in my routine had changed or was non-typical except for the booster shot. It felt very intense during that 12 hour period.
Fever 103F, swelling of leg; Not seen; Mom did not want to bring in for visit; No significant past hx;
Patient describes a sore and weak arm that has remained consistent since the shot. He says that he is active but now cannot do things like pushups or moving his arm up without pain.
red target after the first shot; kept holding my left breast for a week; I feel aware of it, in my left breast., as of now.; red target after the second shot; a terrible pain in my left breast; intense heat right after the shot; shortness of the breath; This spontaneous case was reported by a consumer and describes the occurrence of BREAST PAIN (a terrible pain in my left breast), FEELING HOT (intense heat right after the shot), DYSPNOEA (shortness of the breath), VACCINATION SITE ERYTHEMA (red target after the first shot) and VACCINATION SITE ERYTHEMA (red target after the second shot) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 039A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced FEELING HOT (intense heat right after the shot) and DYSPNOEA (shortness of the breath). On 01-Apr-2021, the patient experienced BREAST PAIN (a terrible pain in my left breast). On 05-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (red target after the second shot) and BREAST PAIN (I feel aware of it, in my left breast., as of now.). On 08-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (red target after the first shot) and BREAST PAIN (kept holding my left breast for a week). At the time of the report, BREAST PAIN (a terrible pain in my left breast), VACCINATION SITE ERYTHEMA (red target after the first shot), VACCINATION SITE ERYTHEMA (red target after the second shot), BREAST PAIN (kept holding my left breast for a week) and BREAST PAIN (I feel aware of it, in my left breast., as of now.) outcome was unknown and FEELING HOT (intense heat right after the shot) and DYSPNOEA (shortness of the breath) had resolved.
Sore throat and a cough over the weekend; Sore throat and a cough over the weekend; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received BNT162B2 (Solution for injection), dose 1 via an unspecified route of administration on an unspecified date as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that the patient was scheduled to receive her second dose of the Covid19 vaccine, tomorrow 27Apr2021. The patient developed a sore throat and a cough over the weekend and wanted to know if she could keep her appointment, tomorrow. The patient did not have a fever, reporting her temperature 26Jan2021 (reported as today) was 97-degree Fahrenheit when it was usually 97.6-degree F. She did not believe these symptoms were due to the first dose of vaccine. It was reported "contraindications and precaution of fever in CONS-who should not get the vaccine and used 'VR-Consumer Inquiry Management (Off-Label or No Info) as there was no mention of cough or sore throat. Outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
mild URI sx @ time of PE, recv DPT;t to 101.6 @ home 1AM 31MAY shaking all extremities 1-2 min + postictal;temp then 102.6;eval @ hosp nl exam;LP & CBC nl;UA negative;felt to be febrile sz;no tx;
Headache on left side which  included pain or sensitivity on the entire left side of my face sort of like a toothache.  I have been taking Tylenol since Saturday. The Tylenol helps but I had take it approximately every 6 hours since the vaccination or the pain become excruciating.
No additional AE's; Caller reporting a temperature excursion / ROTATEQ was administered; This spontaneous report was received from a medical assistant, referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, previous drug reactions, allergies, or concomitant medications were not reported.   On 26-MAR-2021, the patient was vaccinated with an improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) 1 dosage form orally administered, as prophylaxis (lot number 1684149 which has been verified to be valid, expiration date reported and validated as 25-JUN-2021) (product storage error). The administered dose of the vaccine was stored at a temperature of 34.1 degrees Fahrenheit (F), during a time frame of 4 hours 15 minutes, as recorded by a digital data logger. There were previous temperature excursions of 34.8 F, during a time frame of 45 minutes; and 34.7 F, during a time frame of 2 hours and 45 minutes. There were no additional adverse events reported in the patient.   This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2104USA007436: US-009507513-2104USA007270: US-009507513-2104USA007278: US-009507513-2104USA007277:
This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses given after temperature excursion) and PRODUCT STORAGE ERROR (Product storage error) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039F21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses given after temperature excursion) and PRODUCT STORAGE ERROR (Product storage error). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses given after temperature excursion) and PRODUCT STORAGE ERROR (Product storage error) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant products were reported. No treatment information was reported by the reporter.   This case was linked to MOD-2021-403721 (Patient Link).